Gates Foundation Backs Cheap Algae-Grown Omega-3 for Mothers in Poorer Countries

A University of Connecticut project has won a $500,000 Gates Foundation grant to make a cheap, algae-grown source of omega-3 — aimed at a nutrient many mothers in low-income countries lack.

The work, led by UConn assistant professor Mingyu Qiao, targets DHA (docosahexaenoic acid), an omega-3 fatty acid important for infant brain and eye development.

Why DHA specifically

DHA is a structural component of brain and retinal tissue rather than merely a nutrient supporting their function, and it is concentrated there in unusually high proportion.

The demand is greatest during the final trimester and the first two years of life, when brain growth is most rapid. That is when the fatty acid is being incorporated into developing tissue — and it is why maternal status matters, since the fetus and breastfed infant obtain DHA from the mother.

The body can synthesise DHA from a shorter-chain omega-3 found in plant oils, but conversion is inefficient, typically yielding only a small percentage. Dietary intake of preformed DHA is therefore the practical route, and it comes almost entirely from fish and seafood.

Deficiency is common among pregnant and lactating women in low- and middle-income countries, where fish or supplements can be scarce or costly.

Why algae rather than fish

Microalgae are the original source of DHA in the food chain. Fish do not synthesise it — they accumulate it by eating algae, or by eating other fish that did.

Producing it directly from algae therefore skips several trophic levels, with practical consequences. It avoids the marine contaminants — mercury, PCBs — that concentrate up the food chain. It does not depend on wild fish stocks. And the product is suitable for vegetarian diets, which matters in populations where fish consumption is restricted culturally as well as economically.

The trick: brewery waste

The team grows microalgae using spent brewer’s waste as the growth substrate, avoiding the expensive refined sugars and capital-intensive fermentation that make current algal DHA costly.

Feedstock is the dominant cost in this kind of production. Algae grown for DHA are typically cultivated heterotrophically — fed sugar in enclosed fermenters rather than grown on sunlight — because it gives higher yields and better control. Purified sugar is expensive.

Spent grain is what remains after brewing extracts fermentable sugars from malted barley. It still contains carbohydrate and protein, it is produced in enormous volume, and breweries currently treat it as low-value material sold as animal feed or disposed of.

Using it converts a cost into a near-free input, which is where the economics change.

The price target

Pharmaceutical-grade algal DHA runs more than $52 per kilogram; the project aims to slash that.

Cost is the binding constraint on nutritional interventions at population scale. A supplement that works but cannot be afforded reaches nobody, and the arithmetic of supplying millions of pregnant women annually makes per-kilogram price the decisive variable rather than a secondary one.

Local manufacturing

The project — titled Ultra Low-Cost DHA Powder from Algae Grown on Digested Grain Spent — is designed for local manufacturing in Africa, creating jobs while closing a nutrition gap.

That element is more than framing. Spent grain cannot be shipped economically — it is wet, bulky and spoils quickly — so production has to happen near a brewery, which means near where the beer is consumed rather than in a distant facility.

Local production also eliminates import costs and currency exposure, and avoids the supply interruptions that affect imported health commodities. The constraint and the development goal point the same direction, which is unusual and is part of why the approach is attractive.

What comes next

It runs an initial 18-month development phase, with the possibility of further funding to build African production sites.

Considerable work remains between a laboratory result and a product. Growing algae on a variable waste substrate is harder than growing them on defined sugar — composition differs between breweries and batches, and contamination risk is higher. Food-safety standards must be met for a product intended for pregnant women.

Why powder rather than oil or capsules

The project’s emphasis on a DHA powder reflects distribution realities that shape the whole design.

Omega-3 fatty acids oxidise readily on exposure to air, heat and light, and oxidised fish or algal oil develops the rancid taste and smell familiar from degraded supplements. In hot climates without reliable refrigeration, an oil product degrades quickly.

Encapsulating the oil within a dried powder matrix protects it, extending shelf life considerably at ambient temperature. Powder is also lighter and less bulky to transport, does not leak, and can be incorporated into existing foods.

That last property matters most for reach. A supplement requires people to take something additional every day, which depends on supply, cost and adherence. A powder that can be blended into a staple food or an existing fortified product reaches people through channels already functioning — the approach that has worked for iodine in salt and for folic acid in flour.

It is early-stage research, but it reflects a growing push to engineer affordable nutrition where it is needed most. Research news, not medical or dietary advice.